What's breaking now, across thousands of outlets.
(MedPage Today) -- The novel immunomodulatory agent efzofitimod failed to reduce steroid use in pulmonary sarcoidosis, a phase III trial showed. Monthly infusions of the fusion protein targeting the neuropilin 2 receptor had no impact on placebo...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Kansas finally won a Big 12 game. Will Jayhawk fans get another treat, or is the trick on us?
LOUISVILLE SHOULD LOOK TO ATTACK THE EDGES OF STANFORD’S DEFENSE Stanford is rebuilding their program with a new head coach as well as Andrew Luck as the General Manager.
Yaxel Lendeborg has been the talk of the NBA so far this season. The rookie has been magnificent for the Golden State Warriors so far this season, and many people already think he is destined for…
Forest Green chairman Dale Vince announces the club is taking legal action against Peterborough United.
Here is where PFF put Jets' Geno Smith, Garrett Wilson on QB-WR ranking.
Identifying three potential X-factors for the New York Jets' offense versus the Las Vegas Raiders in Week 8.
